Vutuc C, Breitenecker G
Geburtshilfe Frauenheilkd. 1985 Nov;45(11):780-3. doi: 10.1055/s-2008-1036647.
Cytological screening has reduced mortality of cervical cancer in Austria. It has cut mortality of carcinoma of the uterus by one third from 1966 to 1982. In causes of deaths screening has mainly reduced mortality from cancer of other and unspecified parts of uterus. A new nomenclature introduced in 1969 has strengthened the decreasing trend with regard to cancer of other and unspecified parts of uterus and has compensated the screening effect in mortality from cervical carcinoma (the decreasing trend was preceded by an increase). This shift of cervix cancer deaths cases from the position mortality from cancer of other and unspecified parts of uterus to mortality from cervical cancer is the reason that the latter does not reflect the real trend of cervical cancer mortality. The analysis of cervical cancer by birth cohort and age at death (1966-1981) show the effect of screening in the younger births cohorts of age groups 40-44, 45-49 and 50-54 and in older ages of cohorts born in 1927-1932, 1932-1936 and 1937-1941 respectively.
细胞学筛查降低了奥地利宫颈癌的死亡率。从1966年到1982年,它使子宫癌死亡率降低了三分之一。在死因方面,筛查主要降低了子宫其他部位及未明确部位癌症的死亡率。1969年引入的新命名法强化了子宫其他部位及未明确部位癌症死亡率的下降趋势,并抵消了宫颈癌死亡率的筛查效果(下降趋势之前有过上升)。宫颈癌死亡病例从子宫其他部位及未明确部位癌症死亡率转移到宫颈癌死亡率,这就是后者未能反映宫颈癌死亡率真实趋势的原因。按出生队列和死亡年龄(1966 - 1981年)对宫颈癌进行分析,结果显示筛查对年龄组为40 - 44岁、45 - 49岁和50 - 54岁的较年轻出生队列,以及分别出生于1927 - 1932年、1932 - 1936年和1937 - 1941年的较老队列产生了影响。